Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 370
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1250((2S)-N-[(2S,3R)-4-[(2R)-2-tert-butyl-N-(pentan-3-y...)
Affinity DataIC50: 1.90nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1249((2S)-N-[(2S,3R)-4-[(2R)-2-tert-butyl-N-(pentan-3-y...)
Affinity DataIC50: 2.20nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1248((2R)-2-tert-butyl-N-[(2R,3S)-2-hydroxy-3-[(2S)-3-m...)
Affinity DataIC50: 2.20nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1247((2R)-2-tert-butyl-N-[(2R,3S)-2-hydroxy-3-[(2S)-3-m...)
Affinity DataIC50: 2.5nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1244(benzyl N-[(1S)-1-{[(2S,3R)-4-[(2R)-2-tert-butyl-N-...)
Affinity DataIC50: 2.90nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1252((2R)-2-tert-butyl-N-[(2R,3S)-2-hydroxy-3-[(2S,3R)-...)
Affinity DataIC50: 3nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1231(benzyl N-[(1S)-1-{[(2S,3R)-4-[(2R)-N,2-di-tert-but...)
Affinity DataIC50: 3nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1251((2R)-2-tert-butyl-N-[(2R,3S)-2-hydroxy-3-[(2S,3R)-...)
Affinity DataIC50: 3.60nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1245(benzyl N-[(1S)-1-{[(2S,3R)-4-[(2R)-2-tert-butyl-N-...)
Affinity DataIC50: 3.80nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus 2)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1250((2S)-N-[(2S,3R)-4-[(2R)-2-tert-butyl-N-(pentan-3-y...)
Affinity DataIC50: 6.30nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus 2)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1249((2S)-N-[(2S,3R)-4-[(2R)-2-tert-butyl-N-(pentan-3-y...)
Affinity DataIC50: 6.70nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1246(benzyl N-[(1S,2S)-1-{[(2S,3R)-4-[(2R)-2-tert-butyl...)
Affinity DataIC50: 8.20nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1243(benzyl N-[(2S,3R)-4-[(2R)-2-tert-butyl-N-phenylbut...)
Affinity DataIC50: 14nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1239(benzyl N-[(2S,3R)-4-[(2R)-2-tert-butyl-N-(pentan-3...)
Affinity DataIC50: 15nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1238(benzyl N-[(2S,3R)-4-[(2R)-2-tert-butyl-N-(propan-2...)
Affinity DataIC50: 19nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1237(benzyl N-[(2S,3R)-4-[(2R)-N,2-di-tert-butylbutaned...)
Affinity DataIC50: 19nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1232(benzyl N-[(1S)-1-{[(2S,3R)-4-[(2S)-N,2-di-tert-but...)
Affinity DataIC50: 25nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus 2)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1248((2R)-2-tert-butyl-N-[(2R,3S)-2-hydroxy-3-[(2S)-3-m...)
Affinity DataIC50: 38nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1240(benzyl N-[(2S,3R)-4-[(2R)-2-tert-butyl-N-(heptan-4...)
Affinity DataIC50: 39nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus 2)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1247((2R)-2-tert-butyl-N-[(2R,3S)-2-hydroxy-3-[(2S)-3-m...)
Affinity DataIC50: 42nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1236(benzyl N-[(1S)-1-{[(2S,3S)-4-[(2R)-N,2-di-tert-but...)
Affinity DataIC50: 50nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1242(benzyl N-[(2S,3R)-4-[(2R)-2-tert-butyl-N-(2,4-dime...)
Affinity DataIC50: 58nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1229(benzyl N-[(1S)-1-{[(2S,3R)-4-[(2S)-2-(tert-butylca...)
Affinity DataIC50: 62nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1234(benzyl N-[(1S)-1-{[(2S,3R)-4-[(2R)-N,2-di-tert-but...)
Affinity DataIC50: 125nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus 2)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1252((2R)-2-tert-butyl-N-[(2R,3S)-2-hydroxy-3-[(2S,3R)-...)
Affinity DataIC50: 135nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1241(benzyl N-[(2S,3R)-4-[(2R)-2-tert-butyl-N-cyclohexy...)
Affinity DataIC50: 135nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1230(benzyl N-[(1S)-1-{[(2S,3R)-4-{[2-(tert-butylcarbam...)
Affinity DataIC50: 140nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus 2)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1251((2R)-2-tert-butyl-N-[(2R,3S)-2-hydroxy-3-[(2S,3R)-...)
Affinity DataIC50: 185nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1233(benzyl N-[(1S)-1-{[(2S,3R)-4-[(2S)-N,2-di-tert-but...)
Affinity DataIC50: 4.85E+3nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)

LigandPNGBDBM1235(benzyl N-[(1S)-1-{[(2S,3R)-4-(N-tert-butylbutanedi...)
Affinity DataIC50: 8.25E+3nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2004
Entry Details Article
PubMed